Coronary Stents - Emerging Markets (Brazil, Russia, India, China, South Africa And South Korea), 2012-2018

 
Table Of Contents
I. Report Focus
 
 A. Introduction
 
 Cardiology
 
 Kinds Of Cardiac Conditions
 
 A. Blood Flow In The Heart
 
 B. Heart Malfunction
 
 Types Of Cardiac Arrest
 
 C. Myocardium
 
 Disorders Of Myocardium
 
 D. Pericardium
 
 E. Heart Valves
 
 Disorders Of Heart Valves
 
 F. Congenital Heart Defect
 
 Types Of Congenital Heart Defect
 
 G. Ailments Of Blood Vessels (Vascular Diseases)
 
 H. Heart Failure
 
 B. Cardiovascular Devices
 
 Devices For Endovascular Aneurysm Repair And Replacement
 Techniques To Prevent Coronary Blood Vessel Syndrome
 Tools Deployed In Cardiology
 Diagnostic Tests And Procedures
 Conclusion
 
 C. Interventional Cardiology
 
 A. Interventional Diagnostics And Its Technologies
 
 I. Intravenous Ultrasound (Ivus)
 Ii. Optical Coherence Tomography (Oct)
 Iii. Fractional Flow Reserve (Ffr) - A Big Technological Breakthrough
 Implications Of Ffr Growth - Fall In Use Of Guidewires And Des In Patients With Multivessel Stenoses
 Ffr Has Greater Impact On The Global Market In The Long Term
 Emerging Rival Technologies: Ct-Ffr And Ifr
 The Results Of A Clinical Trial Comparing Ifr To Ffr
 Percutaneous Coronary Intervention (Pci)
 
 B. Interventional Cardiac Devices
 
 Coronary Stents
 
 Advances In Stent Technology: Expectations And New Developments
 
 Stent Scaffold Structure
 
 Coronary Stent Coating Types - In Brief
 
 Types Of Stent Coatings, In Brief:-
 
 A. Inorganic Coatings
 
 Gold
 Silicon Carbide
 Iridium Oxide
 Carbon
 Titanium-Nitride-Oxide
 
 B. Polymer Coatings
 
 Non-Biodegradable Polymers
 Biodegradable Polymers
 
 C. Non-Polymer Coatings/Surfaces:
 
 Microporous Surfaces
 Microstructured Surfaces
 Slotted Tubular Surfaces
 Nanoporous Surfaces
 Nps
 Nano-Patterned Surfaces
 
 D. Other Coatings/Strategies
 
 Heparin
 Hyaluronic Acid (Ha)
 Fibrin
 Endothelial Cells (Ec)
 Conclusion
 
 Cardiac Stent Usage In The Us
 
 Procedures Performed
 Preferred Stent Type
 Stent Factors And The Importance Of Vendor Relationships
 
 A. Drug-Eluting Stents (Des)
 
 Diagnostics Likely To Change Des Usage
 Intravenous Diagnostics: The Future Gatekeeper For Stent Usage
 Des: The Next Target For Medical Spending Cuts
 Des At The Forefront Of Price Cuts And Usage Limitation
 Asian-Born Innovation To Target A Declining Des Market In Future
 The Best Stents Available In Market And Innovations Are On The Way
 Growth Trend Of Asian Companies Comparable To Us Companies’ In The Late 90’s
 Us And Japan Breakdown Of Pci Cases
 Global Drug-Eluting Stent Market Likely To Decline
 Next Generation Stents - Bvs, Synergy, Tcd-10023 And Biofreedom
 First-Generation Stents
 Second-Generation Stents
 Third-Generation Stents
 
 B. Bare Metal Stents (Bms)
 
 Bare-Metal And Drug-Eluting Stents Market
 
 C. Absorbable Stents/Biodegradable Metallic Stent
 
 Bioabsorbable Stent Scaffolds
 Self-Expanding Stent Scaffolds
 Micromesh Covered Stent
 Dedicated Bifurcation Stents
 Speculation On Bio-Absorbable Stents
 
 D. Anti-Restenosis Devices
 
 Vasculast - Drug Eluting Coating
 Covidien Commences Patient Enrolment In Anti-Restenosis Study
 Drug Eluting Balloons
 Conclusion
 
 New Directions For Stent Technology
 
 Strong Growth Expected For Bioabsorable Stents In Europe, United States
 Biosensors, Abbott, Art Emerge As Bioabsorable Stent Competitors
 Bifurcated Stents To Enter The U.S. Market, European Market Sees Double Digit Growth
 
 D. Coronary Stents - Types & Stent Coating - Market Briefing
 
 China
 India
 Brazil
 Russia
 South Korea
 South Africa
 
 Ii. Market Analysis
 
 Coronary Stents – Bricss – Industry Snapshot
 
 A. Coronary Stents - Segmentation
 
 Coronary Stents - Global
 Coronary Stents - Bricss
 
 Coronary Stents – By Type
 
 Coronary Stents - Bricss - By Type
 Drug-Eluting Stents (Des)
 Bare Metal Stents (Bms)
 Absorbable Stents
 Anti-Restenosis Devices
 
 Coronary Stents - By Stent Coating
 
 Coronary Stents - Bricss - By Stent Coating
 Inorganic Coating
 Polymer Coating
 Non-Polymer Coating
 Other Stent Coatings
 
 B. Growth Rate Analysis
 
 Bricss Coronary Stents - Market Growth Rates
 Bricss Coronary Stents - Type - Growth Rates
 Bricss Coronary Stents - Stent Coating - Growth Rates
 
 C. Investment Focus
 
 Iii. Industry Overview
 
 Frequent Occurrences Of Cardiovascular Diseases Witness Improvements In Medical Devices For Cardiovascular Applications
 An Encouraging Jab For Torpid Periods
 
 A. A Review On Cardiac Medical Device Types
 
 Cardiac Rhythm Management Devices
 Crm In Europe
 
 Cardiac Defibrillators
 
 Rapid Growth In Defibrillator Sales
 
 Cardiac Pacemaker Devices
 
 The Data Collection Work
 
 Cardiac Resynchronization Therapy (Crt)
 
 Cardiac Monitoring And Diagnostic Devices
 
 The Progressive And Frequent Occurrences Of Heart Diseases To Encourage Huge Demand Of Diagnostic Cardiac Monitoring Systems
 Incorporation Of Systems With Emr To Boost Extended Growth Of Market
 The North American Cardiac Monitoring Devices Market Overview
 
 Interventional Cardiac Devices
 
 Coronary Stents
 Evolution Of Stent Technology Attracts Huge Attention
 
 Ffr Impact On Des Market
 
 Market Forecasts An Impact Of Ffr And Oct On The Des Market
 
 Cardiac Catheters
 
 Competitive Analysis
 
 Electrophysiology Catheters (Ep)
 
 Growth In Electrophysiologists In Europe
 Diagnostic Ep Catheters, Ablation Devices See Strong Industry Growth
 
 Ep Mapping
 
 New Af Ablation Devices Seek Approval
 
 Atrial Fibrillation (Af)
 
 Intravascular Ultrasound (Ivus)
 
 Go With The Flow: Fractional Flow Reserve, That Is
 
 Peripheral Vascular Devices
 
 Arteriotomy Closure Devices
 Embolic Protection Devices (Epd)
 Inferior Vena Cava (Ivc) Filters
 Conclusion
 
 Peripheral Guidewires
 
 Av Access Thrombectomy Devices
 
 Prosthetic Heart Valves
 
 Swiss Cardiovascular Devices: A Market Review
 Market Challenges
 
 B. Cardiac Devices: Mortality Risks V/S Age
 
 Drivers In The Medical Implant Industry
 Size And Weight
 Power Efficiency
 Performance Specifications
 Risk Mitigation And Reliability
 Exciting Future Predicted For Advanced Cardiovascular Devices
 
 C. Cardiac Disease: An Economic Perspective
 
 Cardiovascular Disease (Cvd) And Its Effects On Health And Economy
 Impact Of Cvd In Europe
 Impact On New York State
 Economic Impact Of Cvd In Nys
 Health And Economic Impact Of Heart Disease Prevention
 Impact Of Cvd On Economic Stability
 
 Economic Cost Of Cardiovascular Diseases
 
 Cost Of Cardiovascular Disease To Triple By 2030
 
 Cardiovascular Disease Is Largely Preventable
 
 D. Infectious And Cardiovascular Diseases In Africa And Beyond
 
 E. Recent Fda Actions And Approvals In Cardiovascular Devices
 
 F. Market Trends
 
 Patient Enrollment By Cardiac Dimensions In Titan Ii Clinical Trial
 Cedars-Sinai Heart Institute Study: Stem Cells Augments Heart's Natural Repair Systems
 Ge Healthcare’s Discovery Igs 730 System, An Innovation For Hybrid Operating Rooms
 Ge’s Automated Function Imaging For Daily Clinical Use.
 Cryolife Receives Expanded Indication For Biofoam In Cardiovascular Surgeries In Europe
 Innovative Procedures To Treat Peripheral Artery Disease (Pad)
 Task Force Monitor Demonstrated As Effective Autonomic Biomarker In Cfs Patients
 Innovation In Interventional Cardiology: Catheter Retrieval Of Infective Flora And Movable Clots From Cardiac Valves And Compartments
 Stereo-Taxis Unveils Latest Electrophysiology Platform: Epoch (Tm)
 Vicor Technologies Acquires Fda Clearance Of 510(K) For Its Pd2i Nonlinear Algorithm And Software To Be Employed In Cardiovascular Disease Testing
 Vicor Technologies Acquires Fda Clearance Of 510(K) For Its Pd2i Nonlinear Algorithm And Software To Be Employed In Cardiovascular Disease Testing
 Stereo Taxis Reports Development Of Catheter Strategic Affiliation
 Glp Pre-Medical Studies Exhibit Ncontact Ablation Lesions Are Comprehensive And Transmural
 Modernizations In Interventional Cardiology: Technology, Finances And Political Policies
 B. Braun's Introcan Safety 3 Closed Iv Catheter Is Presented With Top Innovation Award
 Mid Secures First Tranche Of $5 Million Series B Financing
 Research Reveals That Human Hearts Produces New Cells After Birth
 A New Type Of Nerve Cell Identified In The Brain
 Roche To Advance 240 Million Swiss Francs In Diagnostics Production In Germany
 Sorin Group Announces Investment In Highlife.
 First 34 U.S. Patients Implanted With Biotronik’s New Evia Hf-T Pacemaker.
 Aortech Lnternational Plc Claims Material Breach Of Contract By Division Of St. Jude Medical
 Spectranetics Launches U.S Commencement Of The Tapas(Tm) Catheter And Preclinical Animal Data On Drug Uptake In Peripheral Vessels
 Uscom Makes Presentations At World Hypertension Congress
 Mortara Instrument, Inc. Launches “Built With Pride In Milwaukee” Campaign.
 Mallinckrodt Joins Partnership At Drugfree.Org To Introduce Medicine Abuse Project
 Drug-Eluting Stents Are Secure
 Cardiac Science Begs Top Ranking Md Buyline's User Satisfaction Survey
 Artificial Heart Successfully Implanted In A Baby In Japan For The First Time
 Arterial Remodeling Technologies Announces First Human Use Of Its Next-Generation Bioresorbable Stent
 Atrium Medical Corporation Receives Premier Performance Award For Operational Excellence.
 Bayer Healthcare Discloses Advances In Ct Contrast Dose Management Solutions.
 Hrs: Remote Patient Monitoring To Minimize Unplanned Ed Admins
 Future Home Health Care Equipment Trend- Technology Outlook
 Fortune Magazine Named St. Jude Medical As The “Most Admired Company”
 Biotronik Opens New Asia Pacific Headquarters In Singapore
 Cook Medical To Invest €16.5m In Irish Medical Technology Market
 Major Events In Cardiovascular Medical Device Space
 Medical Imaging Equipment Of Siemens Healthcare Wins Largest Order In Latin America.
 Negative Trends In Innovation In Interventional Cardiology Despite Decreases In Cvd Mortality—Interventional Cardiologists Express Anguish
 First Implant Of Boston Scientific's Watchman Device In Patients In Latin America
 Study Reveals That Bayer Healthcare’s Cotavance Drug Eluting Balloons With Paccocath Technology Reduced Target Lesion Revascularization (Tlr) Rates By 59% In Pad Patients Compared To Those Treated With Uncoated Balloons.
 Uscom Presented New Hypertension Management Study At World Hypertension Congress
 Sahajanand Medical Technologies Awarded Medical Device Company Of The Year 2011
 Terumo Corporation, A Well Known Pioneer In Medical Device Technology, Celebrates 90th Anniversary
 Cardica Achieves Landmark Under Distribution Agreement With Century Medical
 Solutions For Sustainable Cardiovascular Care At The European Society Of Cardiology (Esc)
 Excor Pediatric Ventricular Assist Device Recommended By Fda Advisory Panel For Use In The United States.
 Zoll Nominated To Globe 100 Again
 Uscom Enters European Markets
 Positive Growth And Outlook For Biotronik In Usa And Other Markets
 Uscom Secures Strong Presence In Us And Canada
 Cardiomems Among The Top 10 Innovative Technology Companies
 Covidien Introduces New Global Packaging
 Stentys’s Drug-Eluting Stent Receives More Reimbursement In Germany.
 Sorin Group Introduces The Achievement Of A Key Milestone In Aortic Valve Replacement
 Cardiomems Receives Georgia Bio (Gabio) 2011 Deal Of The Year Award
 Uscom Eyes Eastern European Market
 Vcu Successfully Transplanted 900th Total Artificial Heart
 Innovative Trends In Recent Medical Devices
 Infections From Implanted Cardiac Devices
 Tyrx Reaches Milestone In Aigisrx Implantation
 Heart Transplants Substituted By A Pump
 Devices For Treatment Of Atrial Fibrillations (Af)
 Remote Monitoring Of Heart Failure Patients
 Effects Of Remote Monitoring Of Implanted Devices
 Oakwood Hospital And Wayne State University Working On Heart Implantation
 Implantable Cardiac Monitor With Helpful Approach
 Over-The-Counter Apparatus
 Boston Scientifics’ Implantable Defibrillator
 Cardiac Science’s New Cardiac Treatment
 The Only Synchronized Surgical And Catheter Based Atrial Fibrillation
 Cardiac Science Corporation With Cardiac Diseases Healing Method
 Local Medicare’s Coverage For Hypertension With Bioz(R) Icg Technology
 A New Standard In Cardiac Spect Reconstruction
 A Revolutionized Electrophysiology (Ep) For Cardiac
 Lidco Products Accepted In South Korea
 Invention Of Bi-Directional Cardiac Catheter For Irregular Heart Rhythms
 Best And Latest Self-Teaching Heart Sounds
 Replacing Valve Without Cardiac Support
 U.S. Fda Grants The Navistar Thermocool Catheter For Rapid Heart Beat
 An Fda Us Approved Treatment For Clogged Neck Arteries
 New-Fangled Specialty Catheter By Abbott At The Usa
 Medical Implant Markets Under The Influence Of Technical Trends
 
 G. Key Company Profiles
 
 North America
 Europe
 Asia-Pacific
 Rest Of World
 
 Other Key Company Industry Activites / Product Launches
 
 Cardiac Devices Marketed And Pipeline Products
 
 Cardiac Medical Devices – Patents
 
 Key Companies Financial Overview
 
 Iv. Industry Company Database
 
 V. Appendix
 
 Research Focus
 About Axis Research Mind
 Disclaimer
 Feedback

List Of Tables

I. Report Focus

1. Comparison Pci Guideline In Us And Eu For Ivus/Oct/Ffr
2. List Of Dedicated Coronary Bifurcation Stents
3. Currently Available Bare-Metal Coronary Stent Systems
4. Bioabsorbable Scaffolds (Advantages And Disadvantages)
5. List Of Bioabsorbable Stents With Characteristics And Clinical Evidence
6. Contemporary Drug Eluting Balloons
D. Coronary Stents - Types & Stent Coating - Market Briefing

China

7. Coronary Stents Market - Types - Drug-Eluting Stents (Des), Bare Metal Stents (Bms), Absorbable Stents And Anti-Restenosis Devices For China - (2012-2018, In Usd$ Million)
8. Coronary Stents Types - Drug-Eluting Stents (Des), Bare Metal Stents (Bms), Absorbable Stents And Anti-Restenosis Devices - % Of Chinese Market Value - (2015 - 2018)
9. Coronary Stents Market - Stent Coating - Inorganic, Polymer, Non-Polymer And Other Coatings For China - (2012-2018, In Usd$ Million)
10. Coronary Stents - Stent Coating - Inorganic, Polymer, Non-Polymer And Other Coatings - % Of Chinese Market Value - (2015 - 2018)

India

11. Coronary Stents Market - Types - Drug-Eluting Stents (Des), Bare Metal Stents (Bms), Absorbable Stents And Anti-Restenosis Devices For India - (2012-2018, In Usd$ Million)
12. Coronary Stents Types - Drug-Eluting Stents (Des), Bare Metal Stents (Bms), Absorbable Stents And Anti-Restenosis Devices - % Of Indian Market Value - (2015 - 2018)
13. Coronary Stents Market - Stent Coating - Inorganic, Polymer, Non-Polymer And Other Coatings For India - (2012-2018, In Usd$ Million)
14. Coronary Stents - Stent Coating - Inorganic, Polymer, Non-Polymer And Other Coatings - % Of Indian Market Value - (2015 - 2018)

Brazil

15. Coronary Stents Market - Types - Drug-Eluting Stents (Des), Bare Metal Stents (Bms), Absorbable Stents And Anti-Restenosis Devices For Brazil - (2012-2018, In Usd$ Million)
16. Coronary Stents Types - Drug-Eluting Stents (Des), Bare Metal Stents (Bms), Absorbable Stents And Anti-Restenosis Devices - % Of Brazilin Market Value - (2015 - 2018)
17. Coronary Stents Market - Stent Coating - Inorganic, Polymer, Non-Polymer And Other Coatings For Brazil - (2012-2018, In Usd$ Million)
18. Coronary Stents - Stent Coating - Inorganic, Polymer, Non-Polymer And Other Coatings - % Of Brazilin Market Value - (2015 - 2018)

Russia

19. Coronary Stents Market - Types - Drug-Eluting Stents (Des), Bare Metal Stents (Bms), Absorbable Stents And Anti-Restenosis Devices For Russia - (2012-2018, In Usd$ Million)
20. Coronary Stents Types - Drug-Eluting Stents (Des), Bare Metal Stents (Bms), Absorbable Stents And Anti-Restenosis Devices - % Of Russian Market Value - (2015 - 2018)
21. Coronary Stents Market - Stent Coating - Inorganic, Polymer, Non-Polymer And Other Coatings For Russia - (2012-2018, In Usd$ Million)
22. Coronary Stents - Stent Coating - Inorganic, Polymer, Non-Polymer And Other Coatings - % Of Russian Market Value - (2015 - 2018)

South Korea

23. Coronary Stents Market - Types - Drug-Eluting Stents (Des), Bare Metal Stents (Bms), Absorbable Stents And Anti-Restenosis Devices For South Korea - (2012-2018, In Usd$ Million)
24. Coronary Stents Types - Drug-Eluting Stents (Des), Bare Metal Stents (Bms), Absorbable Stents And Anti-Restenosis Devices - % Of South Korean Market Value - (2015 - 2018)
25. Coronary Stents Market - Stent Coating - Inorganic, Polymer, Non-Polymer And Other Coatings For South Korea - (2012-2018, In Usd$ Million)
26. Coronary Stents - Stent Coating - Inorganic, Polymer, Non-Polymer And Other Coatings - % Of South Korean Market Value - (2015 - 2018)

South Africa

27. Coronary Stents Market - Types - Drug-Eluting Stents (Des), Bare Metal Stents (Bms), Absorbable Stents And Anti-Restenosis Devices For South Africa - (2012-2018, In Usd$ Million)
28. Coronary Stents Types - Drug-Eluting Stents (Des), Bare Metal Stents (Bms), Absorbable Stents And Anti-Restenosis Devices - % Of South African Market Value - (2015 - 2018)
29. Coronary Stents Market - Stent Coating - Inorganic, Polymer, Non-Polymer And Other Coatings For South Africa - (2012-2018, In Usd$ Million)
30. Coronary Stents - Stent Coating - Inorganic, Polymer, Non-Polymer And Other Coatings - % Of South African Market Value - (2015 - 2018)
31. Coronary Stents - Product By Brands

Ii. Market Analysis

32. Bricss Coronary Stents - Segmentation By Types

Coronary Stents - Global

33. Coronary Stents Market - Global Current Trends, Estimates & Forecasts - (2012-2018, In Usd$ Million)

Coronary Stents - Bricss

34. Coronary Stents Market - Bricss Current Trends, Estimates & Forecasts - (2012-2018, In Usd$ Million)
35. Coronary Stents Market - Bricss Current Trends, Estimates & Forecasts For China, India, Brazil, Russia, South Korea And South Africa - (2012-2018, In Usd$ Million)
36. Coronary Stents Market - % Of China, India, Brazil, Russia, South Korea And South Africa Market Value - (2015-2018)

Coronary Stents – By Type

37. Coronary Stents Market - Types - Drug-Eluting Stents (Des), Bare Metal Stents (Bms), Absorbable Stents And Anti-Restenosis Devices For Bricss Current Trends, Estimates & Forecasts - (2012-2018, In Usd$ Million)
38. Coronary Stents - Types - Drug-Eluting Stents (Des), Bare Metal Stents (Bms), Absorbable Stents And Anti-Restenosis Devices - % Of Bricss Market Value - (2015-2018)

Coronary Stents - Bricss - By Type

Drug-Eluting Stents (Des)

39. Drug-Eluting Stents (Des) Market - Bricss Current Trends, Estimates & Forecasts For China, India, Brazil, Russia, South Korea And South Africa - (2012-2018, In Usd$ Million)
40. Drug-Eluting Stents (Des) - % Of China, India, Brazil, Russia, South Korea And South Africa Market Value - (2015-2018)

Bare Metal Stents (Bms)

41. Bare Metal Stents (Bms) Market - Bricss Current Trends, Estimates & Forecasts For China, India, Brazil, Russia, South Korea And South Africa - (2012-2018, In Usd$ Million)
42. Bare Metal Stents (Bms) - % Of China, India, Brazil, Russia, South Korea And South Africa Market Value - (2015-2018)

Absorbable Stents

43. Absorbable Stents Market - Bricss Current Trends, Estimates & Forecasts For China, India, Brazil, Russia, South Korea And South Africa - (2012-2018, In Usd$ Million)
44. Absorbable Stents - % Of China, India, Brazil, Russia, South Korea And South Africa Market Value - (2015-2018)

Anti-Restenosis Devices

45. Anti-Restenosis Devices Market - Bricss Current Trends, Estimates & Forecasts For China, India, Brazil, Russia, South Korea And South Africa - (2012-2018, In Usd$ Million)
46. Anti-Restenosis Devices - % Of China, India, Brazil, Russia, South Korea And South Africa Market Value - (2015-2018)

Coronary Stents - By Stent Coating

47. Coronary Stents Market - Stent Coating - Inorganic, Polymer, Non-Polymer And Other Coatings For Bricss Current Trends, Estimates & Forecasts - (2012-2018, In Usd$ Million)
48. Coronary Stents - Stent Coating - Inorganic, Polymer, Non-Polymer And Other Coatings - % Of Bricss Market Value - (2015-2018)

Coronary Stents - Bricss - By Stent Coating

Inorganic Coating

49. Inorganic Market - Bricss Current Trends, Estimates & Forecasts For China, India, Brazil, Russia, South Korea And South Africa - (2012-2018, In Usd$ Million)
50. Inorganic - % Of China, India, Brazil, Russia, South Korea And South Africa Market Value - (2015-2018)

Polymer Coating

51. Polymer Market - Bricss Current Trends, Estimates & Forecasts For China, India, Brazil, Russia, South Korea And South Africa - (2012-2018, In Usd$ Million)
52. Polymer - % Of China, India, Brazil, Russia, South Korea And South Africa Market Value - (2015-2018)

Non-Polymer Coating

53. Non-Polymer Market - Bricss Current Trends, Estimates & Forecasts For China, India, Brazil, Russia, South Korea And South Africa - (2012-2018, In Usd$ Million)
54. Non-Polymer - % Of China, India, Brazil, Russia, South Korea And South Africa Market Value - (2015-2018)

Other Stent Coatings

55. Other Coatings Market - Bricss Current Trends, Estimates & Forecasts For China, India, Brazil, Russia, South Korea And South Africa - (2012-2018, In Usd$ Million)
56. Other Coatings - % Of China, India, Brazil, Russia, South Korea And South Africa Market Value - (2015-2018)
B. Growth Rate Analysis

Bricss Coronary Stents - Market Growth Rates

57. Coronary Stents Market - Bricss - % Growth Rate Forecasts - (2012-2018)

Bricss Coronary Stents - Type - Growth Rates

58. Coronary Stents - Types - % Growth Rate Forecasts For Drug-Eluting Stents (Des), Bare Metal Stents (Bms), Absorbable Stents And Anti-Restenosis Devices - (2012-2018)

Bricss Coronary Stents - Stent Coating - Growth Rates

59. Coronary Stents - Stent Coating - % Growth Rate Forecasts For Inorganic, Polymer, Non-Polymer And Other Coatings - (2012-2018)
C. Investment Focus
61. Coronary Stents - Forecasted Cagr% - 2012-2018 - Top 8 Countries - Usa, Japan, China, France, India, South Korea, Russia And Brazil
61. Coronary Stents - Types - Drug Eluting Stents, Bare Metal Stents, Absorbable Stents And Anti-Restenosis Devices - Forecasted Cagr% - Value - 2012-2018 - Top 8 Countries - Usa, Japan, China, France, India, South Korea, Russia And Brazil
62. Coronary Stents - Coating - Inorganic, Polymer, Non-Polymer And Other & R&D - Forecasted Cagr% - Value - 2012-2018 - Top 8 Countries - Usa, Japan, China, France, India, South Korea, Russia And Brazil

Iii. Industry Overview

63. Intravenous Diagnostics - By Type - Ffr - Geographic Region Current Trends, Estimates & Forecasts For Usa, Japan, Europe And Rest Of World - (2012-2018, In Usd$ Million)
64. Intravenous Diagnostics – By Type - Oct - Geographic Region Current Trends, Estimates & Forecasts For Usa, Japan, Europe And Rest Of World - (2012-2018, In Usd$ Million)
65. Estimated Direct And Indirect Costs Of Cardiovascular Diseases In The United States Of America - (2010, In Usd Billion)
66. Projected Total Costs Of Cardiovascular Diseases In The United States Of America - (2015-2030, In Usd Billion)
67. Estimated Direct And Indirect Costs Of Cardiovascular Disease By Age - (2012, In Usd Billion)
68. Projections Of Crude Cardiovascular Disease Prevalence - (% - 2010-2030) In The United States
69. Projected Direct Medical Costs Of Cardiovascular Disease - ($Usd Billion, 2010-2030) In The United States
70. Projected Indirect Lost Productivity Costs Of Cardiovascular Disease - ($Usd Billion, 2010-2030) In The United States
71. List Of Approvals For Cardiovascular Medical Devices In 2014
72. List Of Approvals For Cardiovascular Medical Devices In 2013
73. Worldwide Key Players Into Cardiovascular Devices Industry That Project Improved Market Activities In The Near Future
74. Coverage Of Cardiac Devices Marketed And Pipeline Products
75. Cardiac Arrhythmias Drug Treatment Product Launches With Generic Name
76. Circadian Rhythm Sleep Disorders Drug Treatment Product Launches With Generic Name - 2014
77. Peripheral Vascular Disease (Pvd) Drug Treatment Product Launches With Generic Name
78. Annual Sales Of Cardiac Therapy Products Marketed By Therapy Area - (2010-2012, In Us$ Million)
79. Abiomed, Inc. - Product Revenue, For 2011-2013 (In Us$ '000)
80. Accellent, Inc. - Net Revenue, For 2011 And 2012 (In Us$ '000)
81. Alere, Inc. - Net Revenue By Market Segment, For 2012 And 2013 (In Us$ '000)
82. Ambu A/S, Inc. - Net Revenue By Market Segment And Geography, For 2012 & 2013 (In Dkk Million)
83. Angiodynamics, Inc. - Net Revenue By Market Segment And Geography, For 2012 & 2013 (In Usd$ '000)
84. Atricure, Inc. - Net Sales By Product In Domestic & International And Geography, For 2012 & 2013 (In Us$ '000)
85. Baxter International, Inc. - Net Sales By Market Segment And Geography, For 2012 & 2013 (In Usd$ Million)
86. Becton, Dickinson & Co - Net Sales By Market Segment, For 2011-2013 (In Usd$ Million)
87. Bioheart, Inc. - Net Sales, For 2011-2013 (In Us$ '000)
88. Biosensors International Group, Ltd. - Net Sales Revenue By Market Segment, Licensing And Geography, For 2012 & 2013 (In Us$ '000)
89. Biotelemetry, Inc. - Net Sales Revenue And Gross Profit, For 2011-2013 (In Us$ '000)
90. Boston Scientific Corporation - Net Revenue By Market Segment And Geography, For 2011-2013 (In Usd$ Million)
91. C. R. Bard, Inc. - Net Revenue By Market Segment And Geography, For 2011-2013 (In Us$ Million)
92. Cardica, Inc. - Net Revenue, For 2011-2013 (In Us$ '000)
93. Compumed. Inc. - Net Revenue By Market Segment, For 2012 And 2013 In Usd
94. Coviden, Inc. - Net Revenue By Market Segment & Geography, For 2011-2013 (In Us$ Million)
95. Coviden, Inc. - Net Revenue By Market Segment, For Usa And Non-Usa For 2011-2013 (In Us$ Million)
96. Conmed Corporation - Net Revenue By Market Segment And Geography, For 2011-2013 (In Us$ '000)
97. Cryolife, Inc. - Net Revenue By Market Segment, For 2011-2013 (In Us$ '000)
98. Cryolife, Inc. - Net Revenue By Geography, For 2011-2013 (In Us$ '000)
99. Deltex Medical Group Plc - Net Revenue By Market Segment, For 2012 And 2013 (In Us$ '000)
100. Digirad Corporation - Net Revenue By Market Segment, For 2011-2013 (In Us$ '000)
101. Drager Medical Ag & Co. Kg - Net Revenue By Market Segment And Geography, For 2012 And 2013 (In Us$ 'Million)
102. Edwards Lifesciences Llc - Net Revenue By Market Segment And Geography, For 2011-2013 (In Us$ 'Million)
103. Endologix, Inc, - Net Revenue By Geography, For 2011-2013 (In Us$ Million)
104. Heartware, Ltd. - Net Revenue By Geography, For 2011-2013 (In Us$ '000)
105. Hospira, Inc. - Net Revenue By Market Segment And Geography, For 2011-2013 (In Us$ Million)
106. Indraprastha Apollo Hospital - Net Revenue, For 2012-2013 (In Indian Rupees)
107. Inspiremd, Ltd. - Net Revenue, For 2012-2013 (In Us$ '000)
108. Johnson & Johnson - Net Revenue By Market Segment And Geography, For 2011-2013 (In Us$ Million)
109. Koninklijke Dsm N.V - Net Revenue By Market Segment And Geography, For 2012 And 2013 In (Euro Million)
110. Lombard Medical Technologies Plc - Net Revenue, For 2011-2013 (In Us$ '000)
111. Opto Circuits (India) Limited - Net Revenue By Consolidated And Standalone, For 2011-2013 (In Indian Rupees)
112. Microport Medical (Shanghai) Co. Ltd - Net Revenue, For 2012 And 2013 Six Months Ended 30th June (In Rmb'000)
113. St. Jude Medical, Inc. - Net Revenue By Market Segment And Geography, For 2011-2013 (Us$ In Million)
114. Ttk - Net Revenue By Market Segment, For 2011-2013 (In Indian Rupees)
115. Cardium Therapeutics, Inc. - Net Revenue, For 2012-2013 Ended For Nine Months (In Us$ Million)
116. Merit Medical Systems, Inc. - Net Revenue By Market Segment, For 2011-2013 (In Us$ '000)
117. Spectranetics International B.V - Net Revenue By Market Segment And Geography, For 2011-2013 (In Us$ '000)
118. Varian Medical - Net Revenue By Market And Geography, For 2011-2013 (In Us$ Million)
119. Teleflex Medical - Net Revenue By Market Segment And Geoagraphy, For 2011-2013 (In Us$ Million)
120. Abbott Vascular Devices - Net Revenue By Market Segment And Geography, For 2011-2013 (In Us$ Million)
121. Medtronic, Inc - Net Revenue By Market Segment And Geography, For 2011-2012 (In Us$ Million)
122. Aortech International Plc - Net Revenue By Geography, For 2011-2013 (In Us$ '000)
123. Volcano Corporation - Net Revenue By Market Segment And Geography, For 2011 & 2012 (In Us$ '000)
124. Philips Medical Systems - Net Revenue By Market Segment And Geography, For 2011 & 2012 (In Us$ '000)
125. Atcor Medical Holdings Limited - Net Revenue By Geoagraphy, For 2012 And 2013 (In Us$ Million)
126. Lidco Group Plc - Net Revenue By Products And Geography, For 2011-2013 (In Gbp? '000)
127. Sorin Group Usa, Inc. - Net Revenue By Market Segment And Geoagraphy, 2011-2013 (In Euro Million)
128. Thoratec Corporation - Net Revenue By Market Segment And Geography, For 2011 & 2012 (In Us$ '000)
129. Stereotaxis, Inc. - Net Revenue By Product And Geography, For 2011 & 2012 (In Usd)
130. F.Hoffmann-La Roche Ltd - Net Revenue By Market Segment, For 2011-2013 (In Chf Million)
131. Pulsion Medical Systems Se - Net Revenue By Product And Geography, For 2012-2013 (In Euro '000)
132. Novadaq Technologies Inc - Net Revenue By Category And Geography, For 2011-2013 (In Usd)
133. Siemens Medical Solutions Usa, Inc. - Net Revenue By Geography And Market Segment, For 2012 And 2013 (In € Million)
134. Fukuda Denshi Co. Ltd - Net Revenue By Market Segment, For 2011-2013 (In Million Yen)
135. Nihon Kohden Corporation - Net Revenue By Market Segment And Geography, For 2011-2013 (In Million Yen)
136. Lepu Medical Technology (Beijing) Co., Ltd - Net Revenue By Market Segment And Geography, For 2011 And 2012 (In Yuan)
137. Asahi Kasei Corporation - Net Revenue By Market Segment And Geography, For 2011-2013 (In ‘?’ Yen) 

To request a free sample copy of this report, please complete the form below.

Enter captcha code*

We never share your personal data. Privacy policy